Procter & Gamble to Acquire Thorne for $3.8 Billion to Boost Health Care Segment

Procter & Gamble is set to acquire dietary supplement brand Thorne for $3.8 billion, a move aimed at expanding its health care segment. This acquisition adds Thorne to P&G's existing portfolio of health and wellness brands, which includes Metamucil, Align, and New Chapter. The deal is expected to be officially announced soon, signaling a significant strategic expansion for the consumer goods giant. AI

RANK_REASON Acquisition of a notable brand by a major consumer goods company. [lever_c_demoted from significant: ic=1 ai=0.0]

Read on 36氪 (36Kr) →

• Align
• CITIC Securities
• Metamucil
• Oral-B
• Procter & Gamble
• Shailesh Jejurikar
• Sina Finance
• Thorne
• Vicks

• product
• funding

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →